CD4⁺ Lymphocyte Involvement in Ocular Behclet's Disease

References

• Michelson J. B., Chisari F. V. Behçet's disease. Surv Ophthalmol 1974; 26: 190
   Google Scholar
• Nussenblatt R. B., Palestine A. G., Chan C. Cyclosporin A therapy in the treatment of intraocular inflammatory disease resistant to systemic steroids and cytotoxic agents. Am J Ophthalmol 1983; 96: 275
   PubMed Web of Science ®Google Scholar
• Benezra D., Cohen E. Treatment and visual prognosis in Behçet's disease. Br J Ophthalmol 1986; 70: 589
   PubMed Web of Science ®Google Scholar
• Shimada K., Yaoita H., Shikano S. Chemotactic activity in the aqueous humor of patients with Behçet's disease. Jap J Ophthalmol 1972; 16: 84
   Google Scholar
• Williams B. D., Lehner T. Immune complexes in Behçet's syndrome and recurrent oral ulceration. Brit Med J 1977; 1: 1387
   PubMedGoogle Scholar
• Shimada K., Kogure M., Kawashima T., Nishioka K. Reduction of complement in Behçet's disease and drug allergy. Medical Biology 1974; 52: 234
   PubMedGoogle Scholar
• Bonass W. A., Bird-Stewart J. A., Chamberlain M. A. Halliburton W. Molecular studies in Behçet's syndrome. Recent Advances in Behçet's Disease, T. Lehner, C. G. Barnes. Royal Society of Medicine Services, London 1986; 37–41
   Google Scholar
• Mizushima Y., Hoshi K., Matsuda T., Takahashi M., Takada H., Kuribayashi S., et al. Skin hypersensitivity to streptococcal antigens and the induction systemic symptoms by the antigens in Behçet's disease. A multicentre study. J Rheumatol 1989; 16: 506
   PubMed Web of Science ®Google Scholar
• Niwa Y., Mizushima Y. Neutrophil-potentiating factors released from stimulated lymphocytes; special references to the increase in neutrophil-potentiating factors from streptococcus-stimulated lymphocytes of patients with Behçet's disease. Clin Exp Immunol 1990; 79: 353
   PubMed Web of Science ®Google Scholar
• Yamana S., Jones S. L., Aoi K., Aoyama T. Lymphocyte subsets in patients in erythema nodosum-like lesions from patients with Behçet's disease. Recent Advances in Behçet's Disease, T. Lehner, C. G. Barnes. Royal Society of Medicine Services, London 1986; 117–121
   Google Scholar
• Kaneko F., Takahashi Y., Muramatsu Y., Miura Y. Immunological studies of aphthous ulcer and erythema nodosum-like eruptions in Behçet's disease. Br J Dermatol 1985; 113: 303
   PubMed Web of Science ®Google Scholar
• Poulter L. W., Lehner T., Duke O. Immunological investigations of recurrent oral ulcers and Behçet's disease. Recent Advances in Behçet's Disease, T. Lehner, C. G. Barnes. Royal Society of Medicine Services, London 1986; 123–128
   Google Scholar
• Yamana S., Jones S. L., Shimamoto T., Shiota T., Aoyama T., Takasugi K. Immunohistological analysis of lymphocytes infiltrating the terminal ileum in patients with intestinal Behçet's disease. Recent Advances in Behçet's Disease, T. Lehner, C. G. Barnes. Royal Society of Medicine Services, London 1986; 129
   Google Scholar
• Lim S. D., Haw C. R., Kim N. I., Fusaro R. M. Abnormalities of T cell subsets in Behçet's syndrome. Arch Dermatol 1983; 119: 307
   PubMedGoogle Scholar
• Sakane T., Kotani H., Takada S., Tsunenatsu T. Functional aberration of T cell subset in patients with Behçet's disease. Arch Rheum 1982; 25: 1343
   Google Scholar
• Fenton R. H., Easom H. A. Behçet's syndrome. A histopatho-logical study of the eye. Arch Ophthalmol 1964; 72: 71
   PubMedGoogle Scholar
• Shikano S. Ocular pathology of Behçet's syndrome. Int Symp on Behçet's Disease, Rome. Karger, New York/Basel 1986; 111–136
   Google Scholar
• Chan C., Nussenblatt R. B., Fujikawa L. S., Palestine A. G., Stevens G., Parver L. M., Luckenbach M. W., Kuwabara T. Sympathetic ophthalmia. Immunopathological findings. Ophthalmol 1986; 93: 690
   PubMed Web of Science ®Google Scholar
• Chan C., Wetzig R. P., Palestine A. G., Kuwabara T., Nusenblatt R. B. Immunopathology of ocular sarcoidosis. Arch Ophthalmology 1987; 105: 1398
   PubMedGoogle Scholar
• Yoshino T., Mukuzono H., Aoki H., Takahashi K., Takeuchi T., Kubonishi I., et al. A novel monoclonal antibody (OPD4) recognising a helper/inducer T cell subset. Am. 1 Pathol 1989; 134: 1939
   Web of Science ®Google Scholar
• Terry L. A., Brown M. H., Beverley P. CL. The monoclonal antibody, UCHLI, recognizes a 180,000 MW component of the leucocyte-common antigen, CD45. Immunology 1988; 64: 331
   PubMed Web of Science ®Google Scholar
• Norton A. J., Ramsey A. D., Smith S. S., Beverley P. C. L., Isaacson P. G. Monoclonal antibody (UCHL1) that recognises normal and neoplastic T cells in routinely fixed tissues. J Clin Pathol 1986; 39: 399
   PubMed Web of Science ®Google Scholar
• Stross W. P., Warnke R. A., Flavell D. J., Flavell S. U., Simmons D., Gatter K. C., et al. Molecule detected in formalin fixed tissue by antibodies MT1, DF-T1, and L60 (Leu-22) corresponds to CD43 antigen. J Clin Pathol 1989; 42: 953
   PubMed Web of Science ®Google Scholar
• Daniele R., Dauber J., Rossman M. Immunological abnormalities in sarcoidosis. Ann Intern Med 1980; 92: 406
   PubMed Web of Science ®Google Scholar
• Botazzo G. F., Pujol-Borrell R., Nanafusa T., Feldmann M. HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 1983; ii: 1115
   Google Scholar
• Pober J. S., Collins T., Gimbrone M. A., Libby P., Reiss C. S. Inducible expression of Class II major histocompatibility complex antigens and the immunogenicity of vascular endothelium. Transplantation 1986; 41: 141
   PubMed Web of Science ®Google Scholar
• Chan C., Hooks J. J., Nussenblatt R. B., Detrick B. Expression of la antigen on retinal pigment epithelium in experimental autoimmune uveoretinitis. Curr Eye Res 1986; 5: 325
   PubMed Web of Science ®Google Scholar
• Risau W., Engelhardt B., Wekerle H. Immune function of the blood-brain barrier: incomplete presentation of protein (auto-) antigens by rat brain microvascular endothelium in vitro. J Cell Biol 1990; 110: 1757
   PubMed Web of Science ®Google Scholar